Thus, TGFβ‐mutant PDA is likely not subject to the tumor cell growth‐suppressive activity of TGFβ yet maintains TGFβ‐driven tumor promotion via the activity of TGFβ on stromal cells. The gene discussed is TGFB1; the disease is Patent ductus arteriosus.